Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to research

Safety and dose modification for patients receiving niraparib

2018185 citationsJournal Article

Authors

Jonathan S. Berek · Stanford University

Ursula A. Matulonis · Dana-Farber Cancer Institute

Ulla Peen · Herlev Hospital

Prafull Ghatage · University of Calgary

Sven Mahner · Ludwig-Maximilians-Universität München

Andrés Redondo · Spanish Ovarian Cancer Research Group

Topics & Keywords

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Oncology

Volume 29, Issue 8, pp. 1784-1792

DOI: 10.1093/annonc/mdy181

Field-Weighted Citation Impact: 7.93

Safety and dose modification for patients receiving niraparib | Researchclopedia

Nicoletta Colombo

· European Institute of Oncology

Ignace Vergote · KU Leuven

Ora Rosengarten · Shaare Zedek Medical Center

Jonathan A. Ledermann · University College London

Mario Javier Pineda

Susan Ellard · University of British Columbia

Jalid Sehouli · Charité - Universitätsmedizin Berlin

Antonio González-Martı́n · Spanish Ovarian Cancer Research Group

Dominique Berton-Rigaud · Institut de Cancérologie de l'Ouest

Radosław Mądry · Poznan University of Medical Sciences

Alexander Reinthaller · Comprehensive Cancer Center Vienna

Sebastien Hazard · Tesaro (United States)

Wenwen Guo · Tesaro (United States)

Mansoor R. Mirza · Rigshospitalet